DV
Dividend Vision

PROK — ProKidney Corp.

ProKidney Corp. (PROK)

Total return is -86.8% over the past 5.1 years, 180.9 points behind SPY at 94.1%. Its deepest 1-year drawdown was 57.4%.

PROK is an equity fund focused on a single company rather than a diversified portfolio. As a stock fund with no reported dividend distribution rate or expense ratio data, it does not function as a traditional income-generating investment vehicle. This holding appeals primarily to investors seeking direct exposure to an individual equity position rather than those pursuing dividend income or diversified sector exposure.

PROK key facts

Asset type
Stock
Asset class
Equity
Inception date
06/30/2021
Last close
$1.33
Market cap
$471,212,992
Average volume
1415368.0
Beta
1.68
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.51